nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Abdominal distress—Metformin—polycystic ovary syndrome	0.163	0.389	CcSEcCtD
Pentazocine—Lightheadedness—Metformin—polycystic ovary syndrome	0.0197	0.0471	CcSEcCtD
Pentazocine—Cramp muscle—Metformin—polycystic ovary syndrome	0.0144	0.0344	CcSEcCtD
Pentazocine—Sweating increased—Metformin—polycystic ovary syndrome	0.0135	0.0322	CcSEcCtD
Pentazocine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0133	0.0317	CcSEcCtD
Pentazocine—Flushing—Metformin—polycystic ovary syndrome	0.0103	0.0245	CcSEcCtD
Pentazocine—Chills—Metformin—polycystic ovary syndrome	0.00993	0.0237	CcSEcCtD
Pentazocine—Dysgeusia—Metformin—polycystic ovary syndrome	0.00943	0.0225	CcSEcCtD
Pentazocine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00926	0.0221	CcSEcCtD
Pentazocine—Vision blurred—Metformin—polycystic ovary syndrome	0.00908	0.0217	CcSEcCtD
Pentazocine—Tremor—Metformin—polycystic ovary syndrome	0.00903	0.0216	CcSEcCtD
Pentazocine—Syncope—Metformin—polycystic ovary syndrome	0.00864	0.0206	CcSEcCtD
Pentazocine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00847	0.0202	CcSEcCtD
Pentazocine—Hypertension—Metformin—polycystic ovary syndrome	0.00832	0.0199	CcSEcCtD
Pentazocine—Shock—Metformin—polycystic ovary syndrome	0.00773	0.0185	CcSEcCtD
Pentazocine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0076	0.0182	CcSEcCtD
Pentazocine—Anorexia—Metformin—polycystic ovary syndrome	0.00749	0.0179	CcSEcCtD
Pentazocine—Hypotension—Metformin—polycystic ovary syndrome	0.00735	0.0175	CcSEcCtD
Pentazocine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00706	0.0169	CcSEcCtD
Pentazocine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00701	0.0167	CcSEcCtD
Pentazocine—Somnolence—Metformin—polycystic ovary syndrome	0.00699	0.0167	CcSEcCtD
Pentazocine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00683	0.0163	CcSEcCtD
Pentazocine—Constipation—Metformin—polycystic ovary syndrome	0.00672	0.0161	CcSEcCtD
Pentazocine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00648	0.0155	CcSEcCtD
Pentazocine—Asthenia—Metformin—polycystic ovary syndrome	0.00564	0.0135	CcSEcCtD
Pentazocine—Pruritus—Metformin—polycystic ovary syndrome	0.00556	0.0133	CcSEcCtD
Pentazocine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00538	0.0128	CcSEcCtD
Pentazocine—Dizziness—Metformin—polycystic ovary syndrome	0.0052	0.0124	CcSEcCtD
Pentazocine—Vomiting—Metformin—polycystic ovary syndrome	0.005	0.0119	CcSEcCtD
Pentazocine—Dermatitis—Metformin—polycystic ovary syndrome	0.00495	0.0118	CcSEcCtD
Pentazocine—Headache—Metformin—polycystic ovary syndrome	0.00493	0.0118	CcSEcCtD
Pentazocine—Nausea—Metformin—polycystic ovary syndrome	0.00467	0.0112	CcSEcCtD
Pentazocine—EBP—uterus—polycystic ovary syndrome	0.00104	0.244	CbGeAlD
Pentazocine—EBP—Metabolism—TH—polycystic ovary syndrome	0.000812	0.00141	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000806	0.0014	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000806	0.0014	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000804	0.00139	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000802	0.00139	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.0008	0.00139	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000796	0.00138	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000794	0.00138	CbGpPWpGaD
Pentazocine—EBP—endocrine gland—polycystic ovary syndrome	0.000792	0.185	CbGeAlD
Pentazocine—EBP—Metabolism—SLC2A4—polycystic ovary syndrome	0.00079	0.00137	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000787	0.00136	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000778	0.00135	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00077	0.00133	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000764	0.00132	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00076	0.00132	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000749	0.0013	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000746	0.00129	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000745	0.00129	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000743	0.00129	CbGpPWpGaD
Pentazocine—EBP—Metabolism—CYP19A1—polycystic ovary syndrome	0.000743	0.00129	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000734	0.00127	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000732	0.00127	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000729	0.00126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000727	0.00126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000723	0.00125	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000714	0.00124	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000712	0.00123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000707	0.00122	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000706	0.00122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000705	0.00122	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000698	0.00121	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.000697	0.00121	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000696	0.00121	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000689	0.00119	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000682	0.00118	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000681	0.00118	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000678	0.00118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000677	0.00117	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000676	0.00117	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000675	0.00117	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000671	0.00116	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000671	0.00116	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000666	0.00115	CbGpPWpGaD
Pentazocine—EBP—Metabolism—GNAS—polycystic ovary syndrome	0.000663	0.00115	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000654	0.00113	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000646	0.00112	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000641	0.00111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000637	0.0011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000634	0.0011	CbGpPWpGaD
Pentazocine—EBP—Metabolism—NCOR1—polycystic ovary syndrome	0.000631	0.00109	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000631	0.00109	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000627	0.00109	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000626	0.00108	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000624	0.00108	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00062	0.00107	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00062	0.00107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000616	0.00107	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000609	0.00106	CbGpPWpGaD
Pentazocine—EBP—Metabolism—CYP1A1—polycystic ovary syndrome	0.000599	0.00104	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000597	0.00103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000595	0.00103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000594	0.00103	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000592	0.00103	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00059	0.00102	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000588	0.00102	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000588	0.00102	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000588	0.00102	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000577	0.001	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000577	0.000999	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00057	0.000989	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000567	0.000982	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000563	0.000976	CbGpPWpGaD
Pentazocine—EBP—Metabolism—MTHFR—polycystic ovary syndrome	0.000558	0.000967	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000553	0.000959	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000553	0.000958	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL6—polycystic ovary syndrome	0.000551	0.000955	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00055	0.000953	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000542	0.000939	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000539	0.000934	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000539	0.000933	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000536	0.000928	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000534	0.000925	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000529	0.000917	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000527	0.000914	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000526	0.000911	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000524	0.000907	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000519	0.0009	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000506	0.000877	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000502	0.00087	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000497	0.000861	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000497	0.000861	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000491	0.000851	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000481	0.000833	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000479	0.00083	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000477	0.000827	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000473	0.000819	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000468	0.000811	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000465	0.000806	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000462	0.0008	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000461	0.000799	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PPARG—polycystic ovary syndrome	0.000453	0.000784	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000451	0.000782	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000449	0.000778	CbGpPWpGaD
Pentazocine—EBP—Metabolism—POMC—polycystic ovary syndrome	0.000446	0.000773	CbGpPWpGaD
Pentazocine—EBP—Metabolism—INS—polycystic ovary syndrome	0.000444	0.000769	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000439	0.000761	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FST—polycystic ovary syndrome	0.000438	0.000758	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000435	0.000754	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000432	0.000749	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00043	0.000746	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000428	0.000741	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000427	0.00074	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000421	0.00073	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000418	0.000725	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000417	0.000723	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000405	0.000701	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000404	0.0007	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000403	0.000699	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.0004	0.000693	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000399	0.000692	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000395	0.000685	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000394	0.000682	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000389	0.000675	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FST—polycystic ovary syndrome	0.000384	0.000665	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000382	0.000662	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000381	0.000661	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000379	0.000657	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000375	0.00065	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000374	0.000649	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000372	0.000645	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000366	0.000635	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000366	0.000634	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000364	0.00063	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000356	0.000617	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000354	0.000614	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000354	0.000613	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000354	0.000613	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000351	0.000608	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000347	0.000602	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000346	0.0006	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000343	0.000594	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000342	0.000593	CbGpPWpGaD
Pentazocine—SIGMAR1—adrenal cortex—polycystic ovary syndrome	0.000341	0.0799	CbGeAlD
Pentazocine—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000335	0.00058	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000333	0.000577	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000329	0.00057	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000328	0.000568	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000326	0.000565	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000324	0.000562	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000322	0.000559	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000321	0.000557	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00032	0.000555	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000316	0.000548	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000311	0.000539	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000309	0.000536	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000306	0.000531	CbGpPWpGaD
Pentazocine—SIGMAR1—endometrium—polycystic ovary syndrome	0.000305	0.0713	CbGeAlD
Pentazocine—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000305	0.000528	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000303	0.000526	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.0003	0.00052	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.0003	0.000519	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000299	0.000518	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000297	0.000514	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000293	0.000507	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000287	0.000498	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000283	0.00049	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000282	0.000489	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000282	0.000489	CbGpPWpGaD
Pentazocine—SIGMAR1—uterus—polycystic ovary syndrome	0.000281	0.0657	CbGeAlD
Pentazocine—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000278	0.000482	CbGpPWpGaD
Pentazocine—SIGMAR1—pituitary gland—polycystic ovary syndrome	0.000276	0.0645	CbGeAlD
Pentazocine—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000276	0.000478	CbGpPWpGaD
Pentazocine—SIGMAR1—adipose tissue—polycystic ovary syndrome	0.000275	0.0643	CbGeAlD
Pentazocine—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000273	0.000473	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000272	0.000471	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000271	0.00047	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000269	0.000466	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000269	0.000465	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000266	0.000461	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000262	0.000455	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000261	0.000452	CbGpPWpGaD
Pentazocine—OPRM1—endocrine gland—polycystic ovary syndrome	0.000259	0.0605	CbGeAlD
Pentazocine—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000257	0.000446	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000254	0.00044	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000248	0.00043	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000247	0.000428	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000247	0.000428	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000247	0.000427	CbGpPWpGaD
Pentazocine—SIGMAR1—adrenal gland—polycystic ovary syndrome	0.000246	0.0577	CbGeAlD
Pentazocine—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000246	0.000426	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000243	0.000421	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000238	0.000413	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000237	0.000411	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000236	0.000409	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000233	0.000404	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000231	0.0004	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00023	0.000399	CbGpPWpGaD
Pentazocine—SIGMAR1—female gonad—polycystic ovary syndrome	0.00023	0.0538	CbGeAlD
Pentazocine—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000229	0.000397	CbGpPWpGaD
Pentazocine—SIGMAR1—vagina—polycystic ovary syndrome	0.000228	0.0534	CbGeAlD
Pentazocine—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000227	0.000393	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000225	0.000389	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000218	0.000377	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000216	0.000375	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000216	0.000375	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000216	0.000374	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000209	0.000362	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000209	0.000362	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000208	0.00036	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000206	0.000357	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000205	0.000355	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000202	0.000351	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000201	0.000349	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000199	0.000345	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000194	0.000337	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000193	0.000335	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00019	0.000329	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000184	0.000319	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000183	0.000317	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000182	0.000316	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000181	0.000313	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000177	0.000307	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000176	0.000304	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000173	0.0003	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000173	0.0003	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.00017	0.000294	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00016	0.000278	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000153	0.000265	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000152	0.000263	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000151	0.000262	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00015	0.00026	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000149	0.000258	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000146	0.000252	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000145	0.000251	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.00014	0.000243	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.00014	0.000243	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000133	0.000231	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000133	0.00023	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000128	0.000223	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000128	0.000221	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	0.000127	0.00022	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000126	0.000218	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000123	0.000213	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000123	0.000213	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000117	0.000202	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000112	0.000194	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000108	0.000187	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	0.000107	0.000186	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000107	0.000186	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000104	0.00018	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000104	0.00018	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.86e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.4e-05	0.000163	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.15e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.03e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.94e-05	0.000138	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.78e-05	0.000118	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	6.33e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	5.55e-05	9.62e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	4.69e-05	8.13e-05	CbGpPWpGaD
